← All organizations
Highest phase reached
Phase 2
First clinical trial
Jan 1, 2008Last known activity
Jun 27, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (12 distinct, 3 trials)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
Recent trials (5)
- NCT06182098Lead sponsorN/AJun 27, 2023
- NCT06182098Overall official - principal investigatorN/AJun 27, 2023
- NCT06182098Reponsible party - principal investigatorN/AJun 27, 2023
- NCT04833907Overall official - principal investigatorPhase 1/Phase 2Apr 1, 2021
- NCT00932841Lead sponsorPhase 1Jan 1, 2008
Details
- Last known activity
- Jun 27, 2023